Benefits and obstacles to cell therapy in neonates: The INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research)

Benefits and obstacles to cell therapy in neonates: The INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research)

Abstract Cell‐based therapies hold promise to substantially curb complications from extreme preterm birth, the main cause of death in children below the age of 5 years. Exciting preclinical studies in experimental neonatal lung injury have provided the impetus for the initiation of early phase clini...

Full description

Bibliographic Details
Main Authors: Bernard Thébaud, Manoj Lalu, Laurent Renesme, Sasha vanKatwyk, Justin Presseau, Kednapa Thavorn, Kelly D. Cobey, Brian Hutton, David Moher, Roger F. Soll, Dean Fergusson
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Stem Cells Translational Medicine
Subjects:
clinical translation
lung injury
mesenchymal stromal cells
preterm birth
regenerative medicine
Online Access:https://doi.org/10.1002/sctm.20-0508

Internet

https://doi.org/10.1002/sctm.20-0508

Similar Items